Francesco Barchiesi
Francesco Barchiesi
Verified email at
Cited by
Cited by
Epidemiology and microbiology of surgical wound infections
A Giacometti, O Cirioni, AM Schimizzi, MS Del Prete, F Barchiesi, ...
Journal of clinical microbiology 38 (2), 918-922, 2000
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility …
JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical Microbiology and Infection 14 (4), 398-405, 2008
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts
JL Rodriguez-Tudela, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical microbiology and infection 9 (8), i-viii, 2003
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing
AL Colombo, F Barchiesi, DA McGough, MG Rinaldi
Journal of Clinical Microbiology 33 (3), 535-540, 1995
Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750
F Barchiesi, D Calabrese, D Sanglard, L Falconi Di Francesco, F Caselli, ...
Antimicrobial agents and chemotherapy 44 (6), 1578-1584, 2000
International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole …
A Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, MA Pfaller, M Rinaldi, ...
Journal of clinical microbiology 43 (8), 3884-3889, 2005
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical …
F Barchiesi, AL Colombo, DA McGough, MG Rinaldi
Journal of Clinical Microbiology 32 (10), 2494-2500, 1994
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing …
M Cuenca-Estrella, CB Moore, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical microbiology and infection 9 (6), 467-474, 2003
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital
A Bedini, C Venturelli, C Mussini, G Guaraldi, M Codeluppi, V Borghi, ...
Clinical microbiology and infection 12 (1), 75-80, 2006
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
F Barchiesi, E Spreghini, S Tomassetti, A Della Vittoria, D Arzeni, ...
Antimicrobial agents and chemotherapy 50 (8), 2719-2727, 2006
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)
MC Arendrup, N Friberg, M Mares, G Kahlmeter, J Meletiadis, J Guinea, ...
Clinical Microbiology and Infection 26 (11), 1464-1472, 2020
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa
A Giacometti, O Cirioni, F Barchiesi, M Fortuna, G Scalise
Journal of Antimicrobial Chemotherapy 44 (5), 641-645, 1999
In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically
A Giacometti, O Cirioni, F Barchiesi, MS Del Prete, M Fortuna, F Caselli, ...
Antimicrobial agents and chemotherapy 44 (6), 1694-1696, 2000
Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans
F Barchiesi, AM Schimizzi, F Caselli, A Novelli, S Fallani, D Giannini, ...
Antimicrobial agents and chemotherapy 44 (9), 2435-2441, 2000
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
MC Arendrup, J Meletiadis, JW Mouton, J Guinea, M Cuenca-Estrella, ...
Clinical microbiology and infection 22 (6), 571. e1-571. e4, 2016
In vitro activity of itraconazole against fluconazole-susceptible and-resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus
F Barchiesi, AL Colombo, DA McGough, AW Fothergill, MG Rinaldi
Antimicrobial agents and chemotherapy 38 (7), 1530-1533, 1994
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics
A Giacometti, O Cirioni, F Barchiesi, G Scalise
Diagnostic microbiology and infectious disease 38 (2), 115-118, 2000
Antimicrobial activity of polycationic peptides
A Giacometti, O Cirioni, F Barchiesi, MS Del Prete, G Scalise
Peptides 20 (11), 1265-1273, 1999
In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Candida Species
F Barchiesi, AM Schimizzi, AW Fothergill, G Scalise, MG Rinaldi
European Journal of Clinical Microbiology and Infectious Diseases 18, 302-304, 1999
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles
F Barchiesi, L Falconi Di Francesco, G Scalise
Antimicrobial Agents and Chemotherapy 41 (8), 1812-1814, 1997
The system can't perform the operation now. Try again later.
Articles 1–20